Safety of Clostridium butyricum TO‐A as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Journal · 2025-05 · 23 (5)
DOI: 10.2903/j.efsa.2025.9371 ↗Kurz gefasst
Fachartikel in der Zeitschrift EFSA Journal, 2025-05. Verfasst von EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) und 27 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on Clostridium butyricum TO‐A as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF, which is proposed by the applicant to be used as a food supplement, is sufficiently characterised. The information provided on the production process, composition, stability and specifications of the NF is sufficient and does not raise safety concerns. Based on the findings of a repeated dose 90‐day oral toxicity study in rats, and considering an uncertainty factor of 200, the Panel estimated a safe dose in humans of 4.5 × 106 colony forming unit (CFU)/kg body weight (bw) per day. However, considering that appropriate initial bacteria colonisation of the gastrointestinal tract in humans, in particular during the first 3 years of life, profoundly affects health during infancy and childhood, that disruptions to the microbiota early in life can have lasting health effects into adulthood, and taking into account that the 90‐day oral toxicity study was conducted in adult rats, the Panel considers that the target population for the NF should be restricted to children above 3 years of age, adolescents and adults, excluding pregnant and lactating women. The Panel concludes that the NF, C. butyricum TO‐A, is safe at 1.0 × 108 CFU/day for other children (3 to < 10 years), 2.0 × 108 CFU/day for adolescents from 10 to < 14 years, 2.8 × 108 CFU/day for adolescents from 14 to < 18 years and 3.2 × 108 CFU/day for adults, excluding pregnant and lactating women.
Schlagwörter
Stichwörter der Autor:innen
Zitieren
APA
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck, D., Bohn, T., Cámara, M., Castenmiller, J., De Henauw, S., Jos, Á., Maciuk, A., Mangelsdorf, I., McNulty, B., Naska, A., Pentieva, K., Siani, A., Thies, F., Aguilera-Gómez, M., Cubadda, F., Frenzel, T., Heinonen, M., Knutsen, H. K., …, & Hirsch-Ernst, K. I. (2025). Safety of Clostridium butyricum TO‐A as a novel food pursuant to Regulation (EU) 2015/2283. EFSA Journal, 23(5). https://doi.org/10.2903/j.efsa.2025.9371
Vancouver
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Cámara M, Castenmiller J, De Henauw S, et al. Safety of Clostridium butyricum TO‐A as a novel food pursuant to Regulation (EU) 2015/2283. EFSA Journal. 2025;23(5). doi:10.2903/j.efsa.2025.9371
BibTeX
@article{EFSAPanelonNutritionNovelFoodsandFoodAllergensNDA2025,
author = {EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) and Turck, Dominique and Bohn, Torsten and Cámara, Montaña and Castenmiller, Jacqueline and De Henauw, Stefaan and Jos, Ángeles and Maciuk, Alexandre and Mangelsdorf, Inge and McNulty, Breige and Naska, Androniki and Pentieva, Kristina and Siani, Alfonso and Thies, Frank and Aguilera-Gómez, Margarita and Cubadda, Francesco and Frenzel, Thomas and Heinonen, Marina and Knutsen, Helle Katrine and Neuhäuser-Berthold, Monika and Poulsen, Morten and Prieto Maradona, Miguel and Schlatter, Josef Rudolf and Siskos, Alexandros and van Loveren, Henk and Ackerl, Reinhard and Kagkli, Dafni Maria and Hirsch-Ernst, Karen Ildico},
title = {Safety of Clostridium butyricum TO‐A as a novel food pursuant to Regulation (EU) 2015/2283},
journal = {EFSA Journal},
year = {2025},
volume = {23},
number = {5},
doi = {10.2903/j.efsa.2025.9371}
}
EUVIMED